Silver Ronald 4

What Happened
Ronald Silver, Principal Accounting Officer of Ironwood Pharmaceuticals (IRWD), sold a total of 24,173 shares of IRWD stock in two transactions on Feb 23–24, 2026. The sales were for tax withholding on vested restricted stock units (automatic "sell-to-cover" transactions), not discretionary trades. Details: 11,552 shares sold on 2026-02-23 at a weighted average price of $3.81 for proceeds of $44,013, and 12,621 shares sold on 2026-02-24 at a weighted average price of $3.66 for proceeds of $46,193 (combined proceeds ≈ $90,206).

Key Details

• Transaction dates & amounts:
  • 2026-02-23: 11,552 shares @ weighted avg $3.81 → $44,013 (prices in range $3.70–$4.05; see footnote F2)
  • 2026-02-24: 12,621 shares @ weighted avg $3.66 → $46,193 (prices in range $3.60–$3.73; see footnote F3)
• Total shares sold: 24,173; total proceeds ≈ $90,206.
• Purpose: sell-to-cover to satisfy tax withholding on vested restricted stock units (footnote F1); these sales were automatic and not discretionary.
• Filing: Form 4 filed 2026-02-25 covering transactions on Feb 23–24, 2026 — appears to be timely.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote offers: the filer will provide detailed breakdown of number of shares sold at each price within the reported ranges upon request (per F2/F3).

Context
Sell-to-cover transactions are routine when restricted stock units vest and are used solely to meet tax withholding obligations; they do not necessarily indicate the insider’s view on the company’s prospects. The filing reports sales (code S) rather than purchases, so this is not a bullish insider buy signal.